Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema

Retina

Volumn 31, Issue 4, 2011, Pages 748-754

  Shimura, Masahiko ^a   Yasuda, Kanako ^a   Nakazawa, Toru ^b   Hirano, Yoshio ^c   Sakamoto, Taiji ^d   Ogura, Yuichiro ^c   Shiono, Takashi ^e  

^a NTT East Tohoku Hospital   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e Shiono Eye Cente   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; CENTRAL MACULAR THICKNESS; DIABETIC MACULAR EDEMA; DIFFUSE DIABETIC MACULAR EDEMA; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; PREOPERATIVE EVALUATION; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; SEROUS RETINAL DETACHMENT; TREATMENT OUTCOME; VISION; VISUAL SYSTEM PARAMETERS;

AGED; DIABETIC RETINOPATHY; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 79955053069     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181f04991     Document Type: Article

References (26)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema, report #1. Arch Ophthalmol 1985;103:1796-1806.
2. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 1999;14:223-232. (Pubitemid 30061165)
3. Ma JX, Zhang SX, Wang JJ. Down-regulation of angiogenic inhibitors: a potential pathogenic mechanism for diabetic complications. Curr Diabetes Rev 2005;1:183-196.
4. Montero JA, Ruiz-Moreno JM, De La Vega C. Incomplete posterior hyaloid detachment after intravitreal pegaptanib injection in diabetic macular edema. Eur J Ophthalmol 2008;18:469-472.
5. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927. (Pubitemid 34465226)
6. Massin P, Andren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic macular edema-preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-225.
7. Sutter FK, Simpson JM, Gilles MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004;111:2044-2049. (Pubitemid 39446723)
8. Otani K, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999;127:688-693. (Pubitemid 29266745)
9. Kim BY, Smith SD, Kaiser PK. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 2006; 142:405-412.
10. Yanoff M, Fine BS, Brucker AJ, Eagle RC Jr. Pathology of human cystoid macular edema. Surv Ophthalmol 1984;28:505-511. (Pubitemid 14076510)
11. Guney S, Shuler A, Otta A, et al. Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels. Am J Physiol Lung Cell Mol Physiol 2007;293:L1332-L1338. (Pubitemid 350159418)
12. Otani K, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 2000;129:487-494. (Pubitemid 30184920)
13. Weinberger D, Fink-Cohen S, Gaton DD, et al. Nonretinovascular leakage in diabetic maculopathy. Br J Ophthalmol 1995;79:728-731.
14. Antonetti DA, Barber AJ, Khin S, et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occlusion content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953-1959. (Pubitemid 28549205)
15. Miura Y, Roider J. Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells. Graefe's Arch Clin Exp Ophthalmol 2009;247: 641-649.
16. Oh J, Jung YS, Kim GS, et al. The effect of short-term exposure of triamcinolone acetonide on fibroblasts and retinal pigment epithelial cells. Acta Ophthalmol Scand 2007;85:786-790. (Pubitemid 47616798)
17. Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997;46:1473-1480. (Pubitemid 27369086)
18. Handa Y, Kobayashi H, Kawano H, et al. Steroid and hyperosmotic diuretic effects on the early phase of experimental vasogenic oedema. Acta Neurochir Suppl 1990;51:107-109.
19. Soheilian M, Ramezani A, Obudi A, et al. Randomized trial of intravitreal bevacizumab alone or combined with triamicinolone versus macular photocoagulation in diabetic macular edema. Ophthalmology 2009;116:1142-1150.
20. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-1459.
21. Gaucher D, Sebah C, Erginay A, et al. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 2008;145:289-296.
22. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22:759-767. (Pubitemid 35462506)
23. Yang C, Cheng C, Lee F, et al. Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand 2001;79:266-270. (Pubitemid 32577311)
24. Hee MR, Puliafito CA, Duker JS, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 1998;105:360-370. (Pubitemid 28090845)
25. Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, et al. Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci 2002;43: 1588-1594. (Pubitemid 34462662)
26. Kierman DF, Hariprasad SM, Chin EK, et al. Prospective comparison of Cirrus and Stratus optical coherence tomography for quantifying retinal thickness. Am J Ophthalmol 2009; 147:267-275.